Franklin, MA, United States of America

Jacob D Feala

This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Eisai R&d Management Co., Ltd., Flagship Pioneering Innovations Vi, LLC. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacob D Feala. Retrieved from https://idiyas.com/inventor/jacob-d-feala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 6.7

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jacob D. Feala: Innovator in Protein Optimization and Cancer Research

Introduction

Jacob D. Feala is a notable inventor based in Franklin, MA (US). He has made significant contributions to the fields of protein optimization and cancer research. With a total of 3 patents to his name, Feala's work focuses on enhancing the humanization of proteins and understanding the implications of specific mutations in cancer.

Latest Patents

One of Jacob D. Feala's latest patents is titled "Optimizing Proteins Using Model Based Optimizations." This innovative approach addresses the challenges of humanizing proteins, which can often be a labor-intensive process. By employing neural networks, Feala's method generates new protein sequences that have a higher probability of being humanized. The process includes evaluating the immunogenicity of a sampling of protein sequences and weighting them according to their estimated probabilities. This results in generated protein sequences that possess altered immunogenicity, thereby increasing the likelihood of successful humanization.

Another significant patent by Feala is related to "Splice Variants Associated with Neomorphic SF3B1 Mutants." This application describes methods for detecting these splice variants, which are crucial for diagnosing cancer and evaluating modulators of SF3B1. The research also explores treatment methods for cancers associated with mutations in SF3B1, highlighting the potential impact of his work on cancer therapies.

Career Highlights

Jacob D. Feala has worked with prominent companies in the biotechnology sector, including Eisai R&D Management Co., Ltd. and Flagship Pioneering Innovations VI, LLC. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout his career, Jacob has collaborated with talented individuals such as Lihua Yu and Kian Huat Lim. These partnerships have fostered innovation and have been instrumental in advancing his research initiatives.

Conclusion

Jacob D. Feala is a distinguished inventor whose work in protein optimization and cancer research has the potential to transform therapeutic approaches. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge and improving human health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…